Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

• Status: ACTIVE_NOT_RECRUITING
• Trial end date: 2026-12-31

Summary

A prospective, single-center, phase II clinical study of adebrelimab combined with apatinib in the treatment of unresectable stage III NSCLC patients with grade 2 radiation pneumonitis after definitive chemoradiotherapy

• Phase: PHASE2

Details

• Lead Sponsor: Wei Zhou
• Treatments: Angiogenesis Inhibitors; apatinib; Immune Checkpoint Inhibitors; Immunotherapy